Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2997585 | 0.92 | — | — | |
| SCHEMBL1408585 | 0.77 | — | — | |
| SCHEMBL16241746 | 0.77 | — | — | |
| SCHEMBL189164 | 0.77 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL122871 | 0.74 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL7007888 | 0.74 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL6155112 | 0.74 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL15602717 | 0.74 | — | — | |
| SCHEMBL23451872 | 0.72 | — | — | |
| SCHEMBL17044557 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9983441-B2 | Liquid crystal display device | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | claimed |
| CN-108690195-B | Composition for flexible substrate and flexible substrate | 奇美实业股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-113727999-A | Methods and compositions for treating cancer | 奥默罗斯公司 | 2021-11-30 | — | — | CN | disclosed |
| US-10059881-B2 | Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2018-08-28 | — | — | US | disclosed |
| US-9983441-B2 | Liquid crystal display device | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-20160168465-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | TOYO GOSEI CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20150261044-A1 | LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10059881-B2 | Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device | SP1, ZYX, NOD1 | ALDH1A1 4087/4885 |
| US-20160168465-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | SP1, ZYX, NOD1 | ALDH1A1 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.